NCT03979599

Safety and Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Ultra-sound Guided Transversus Abdominis Plan Block in Pediatric Abdominal Cancer Surgery

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: South Egypt Cancer Institute · Academic / Other
• Sex: All
• Age: 1 Year – 7 Years
• Healthy volunteers: Not accepted

Summary

To study the efficacy of magnesium sulphate as adjuvant to levobupivacaine in transversus abdominis plane (TAP) block in patient undergoing abdominal cancer surgery.

Detailed description

In this randomized study, patients with (ASA) Ӏ and ӀӀ, aged from 1 to 7 years old and their weight less than 30 Kg of both sex will undergo surgery will be enrolled. A written informed consent from all parents are obtained

Conditions

• Postoperative Pain

Interventions

Type	Name	Description
PROCEDURE	ultra-sound guided transversus abdominis plan block	comparing ultrasound guided transversus abdominis plan block using combination of magnisum sulphate and levobupivacaine versus levobupivacaine
DRUG	magnesium sulphate& levobupivacaine	magnesium sulphate\& levobupivacaine
DRUG	Levobupivacaine	levobupivacaine

Timeline

• Start date: 2019-04-15
• Primary completion: 2023-06-01
• Completion: 2023-06-30
• First posted: 2019-06-07
• Last updated: 2023-04-19

Locations

1 site across 1 country: Egypt